Russia’s Coronavirus Drug to Be Sold in 23 Countries
Russia’s coronavirus treatment drug Avifavir will be made available in 17 more countries in addition to the six countries where it is already sold, Russia’s sovereign wealth fund said in a statement Thursday. Avifavir, manufactured by Russia’s ChemRar biotechnology firm, was the world’s first drug to be registered for coronavirus treatment. Belarus, Bolivia, Kazakhstan, Kyrgyzstan, Turkmenistan…